The literature demonstrated that the adoptive transfer of CD4+CD25+ Tregs yielded neuroprotective effects through the suppression of microglial responses to stimuli in an animal model of Parkinson’s disease [24]. This evidence concerns the gene CD4 and Parkinson disease.